Decoding the molecular heterogeneity of pediatric monomorphic post–solid organ transplant lymphoproliferative disorders
Blood · 2023
DOI: 10.1182/blood.2022019543 ↗Kurz gefasst
Fachartikel in der Zeitschrift Blood, 2023. Verfasst von Julia Salmerón-Villalobos und 26 weiteren Autor:innen. Beteiligte Einrichtung: Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain. Hauptthemen laut MEDLINE: Burkitt Lymphoma, Epstein-Barr Virus Infections, Lymphoma, Large B-Cell, Diffuse, Lymphoproliferative Disorders. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 48 Literaturangaben.
Abstract (Originalsprache)
Posttransplant lymphoproliferative disorders (PTLDs) represent a broad spectrum of lymphoid proliferations, frequently associated with Epstein-Barr virus (EBV) infection. The molecular profile of pediatric monomorphic PTLDs (mPTLDs) has not been elucidated, and it is unknown whether they display similar genetic features as their counterpart in adult and immunocompetent (IMC) pediatric patients. In this study, we investigated 31 cases of pediatric mPTLD after solid organ transplantation, including 24 diffuse large B-cell lymphomas (DLBCLs), mostly classified as activated B cell, and 7 cases of Burkitt lymphoma (BL), 93% of which were EBV positive. We performed an integrated molecular approach, including fluorescence in situ hybridization, targeted gene sequencing, and copy number (CN) arrays. Overall, PTLD-BL carried mutations in MYC, ID3, DDX3X, ARID1A, or CCND3 resembling IMC-BL, higher mutational burden than PTLD-DLBCL, and lesser CN alterations than IMC-BL. PTLD-DLBCL showed a very heterogeneous genomic profile with fewer mutations and CN alterations than IMC-DLBCL. Epigenetic modifiers and genes of the Notch pathway were the most recurrently mutated in PTLD-DLBCL (both 28%). Mutations in cell cycle and Notch pathways correlated with a worse outcome. All 7 patients with PTLD-BL were alive after treatment with pediatric B-cell non-Hodgkin lymphoma protocols, whereas 54% of patients with DLBCL were cured with immunosuppression reduction, rituximab, and/or low-dose chemotherapy. These findings highlight the low complexity of pediatric PTLD-DLBCL, their good response to low-intensity treatment, and the shared pathogenesis between PTLD-BL and EBV-positive IMC-BL. We also suggest new potential parameters that could help in the diagnosis and the design of better therapeutic strategies for these patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.
- Centro de Investigación Biomédica en Red-Oncología, Madrid, Spain.
- Hematopathology Unit, Hospital Clínic, University of Barcelona, Barcelona, Spain.
- Pediatric Hematology and Oncology Department, Hospital Universitario La Paz, Translational Research in Pediatric Oncology, Hematopoietic Transplantation and Cell Therapy, Instituto de Investigación Sanitaria del Hospita…
- Pathology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
- Pathology Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
ORCID-Profile: Julia Salmerón-Villalobos, Natalia Castrejón-de-Anta, Pilar Guerra-García, Joan Enric Ramis-Zaldivar, Mónica López-Guerra, Sara Mato, Dolors Colomer, Francisco Diaz-Crespo, Marta Garrido-Pontnou, Mara Andrés, Eugenia García-Fernández, Gerard Frigola, Blanca González-Farré, Idoia Martín-Guerrero, Carmen Garrido-Colino, Itziar Astigarraga, Jaime Verdú-Amorós, Berta González, Elías Campo, Olga Balagué, Itziar Salaverria
Zitieren
APA
Salmerón-Villalobos, J., Castrejón-de-Anta, N., Guerra-García, P., Ramis-Zaldivar, J. E., López-Guerra, M., Mato, S., Colomer, D., Diaz-Crespo, F., Menarguez, J., Garrido-Pontnou, M., Andrés, M., García-Fernández, E., Llavador, M., Frigola, G., García, N., González-Farré, B., Martín-Guerrero, I., Garrido-Colino, C., Astigarraga, I., …, & Salaverria, I. (2023). Decoding the molecular heterogeneity of pediatric monomorphic post–solid organ transplant lymphoproliferative disorders. Blood. https://doi.org/10.1182/blood.2022019543
Vancouver
Salmerón-Villalobos J, Castrejón-de-Anta N, Guerra-García P, Ramis-Zaldivar JE, López-Guerra M, Mato S, et al. Decoding the molecular heterogeneity of pediatric monomorphic post–solid organ transplant lymphoproliferative disorders. Blood. 2023. doi:10.1182/blood.2022019543
BibTeX
@article{SalmernVillalobos2023,
author = {Salmerón-Villalobos, Julia and Castrejón-de-Anta, Natalia and Guerra-García, Pilar and Ramis-Zaldivar, Joan Enric and López-Guerra, Mónica and Mato, Sara and Colomer, Dolors and Diaz-Crespo, Francisco and Menarguez, Javier and Garrido-Pontnou, Marta and Andrés, Mara and García-Fernández, Eugenia and Llavador, Margarita and Frigola, Gerard and García, Noelia and González-Farré, Blanca and Martín-Guerrero, Idoia and Garrido-Colino, Carmen and Astigarraga, Itziar and Fernández, Alba and Verdú-Amorós, Jaime and González-Muñíz, Soledad and González, Berta and Celis, Verónica and Campo, Elías and Balagué, Olga and Salaverria, Itziar},
title = {Decoding the molecular heterogeneity of pediatric monomorphic post–solid organ transplant lymphoproliferative disorders},
journal = {Blood},
year = {2023},
doi = {10.1182/blood.2022019543}
}
EUVIMED